tm logo
TEZSPIRE
Live/Registered
REGISTERED

on 13 Dec 2022

Last Applicant/ Owned by

One Amgen Center Drive

Thousand Oaks

CA

913201799

Serial Number

90873127 filed on 09th Aug 2021

Registration Number

6926330 registered on 13th Dec 2022

in the Principal Register

Correspondent Address

Elsa D. Lemoine

AMGEN INC.

One Amgen Center Drive

Trademark Operations - MS 28-5-A

Thousand Oaks, CA 91320-1799

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

TEZSPIRE

The mark consists of Triangular design with an opening on each side with the wording, TEZSPIRE. Pharmaceutical preparations for the treatment of respiratory diseases and disorders, pulmonary diseases and disorders, inflammation, inflammatory diseases and disorders, neurological diseases and disorders and metabolic diseases and disorders

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of respiratory diseases and disorders, pulmonary diseases and disorders, inflammation, inflammatory diseases and disorders, neurological diseases and disorders and metabolic diseases and disorders


First Use Date in General

27th Dec 2021

First Use Date in Commerce

27th Dec 2021

Specimens


TEZSPIRE specimen

Mark Details


Serial Number

No 90873127

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM-2156-US-1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.05.03 -

Incomplete triangles (must have two angles)

Description of Design Search

The mark consists of Triangular design with an opening on each side with the wording, TEZSPIRE.

Legal History


Show more

Status DateAction Taken
13th Dec 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
13th Dec 2022REGISTERED-PRINCIPAL REGISTER
09th Nov 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08th Nov 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05th Oct 2022STATEMENT OF USE PROCESSING COMPLETE
05th Oct 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
22nd Sep 2022USE AMENDMENT FILED
22nd Sep 2022TEAS STATEMENT OF USE RECEIVED
19th Jul 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
24th May 2022PUBLISHED FOR OPPOSITION